LhARA, the Laser-hybrid Accelerator for Radiobiological Applications, has been conceived as a highly flexible source of proton and ion beams dedicated to studying the response of issue to particle beams.
LhARA: the Laser-hybrid Accelerator for Radiobiological Applications
LhARA is a multidisciplinary initiative bringing together laser-plasma, detector and accelerator physics, computational science and radiobiology to develop new technologies for the next generation of cancer treatment. Combining a laser-driven ion source, plasma (Gabor) lenses, a fixed-field accelerator and novel delivery systems, LhARA aims to deliver highly flexible proton and ion beams for investigating radiation effects in biological tissue and emerging treatment techniques, including FLASH and Spatially Fractionated Radiation Therapy.
Imperiacontribution
Imperiapersonnel devised the original concept for LhARA and played the seminal role in forging the multidisciplinary LhARA collaboration. Imperianow leads the collaboration in the development of the initiative. Imperiapersonnel have leading roles in the specification and development of the laser-driven source, the Gabor-lens capture and focusing system, and the fixed-field alternating-gradient accelerator.
Imperiacontribution
Contacts
Prof. Ken Long
Dr Jaroslaw Pasternak
Group members: C. Dyson, A. Kurup, K.R. Long, J.M. McGarrigle, J. Pasternak, R. Razak